ClinicalTrials.govpublic full text
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
renal cell carcinoma, neoplasm metastases, mrcc, sunitinib, gemcitabine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 887788
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.